Resources

Videos, brochures, research and testimonials to help you learn more about ActiGraft® and the benefits of using this revolutionary new chronic wound treatment.

ActiGraft Kit Procedure

Provider Testimonials

Patient Testimonials

Clinical Papers

Efficacy & Safety of a Novel Autologous Wound Matrix in the Management of Complicated, Chronic Wounds: A Pilot Study

Read Article →

Safety and Efficacy of an Autologous Blood Clot Product (RD1) in the Management of Texas 1A or 2A Neuropathic Diabetic Foot Ulcers: A Prospective, Multicenter, Open Label Pilot Study

Read Article →

The safety of an autologous whole blood clot product applied to full thickness dermal wounds in a porcine model for up to 18 days

Read Article →

Proposed Mechanism of Action of Topically Applied Autologous Blood Clot Tissue

Read Article →

CME/CE, CMPE Webinar

Join our pre-recorded webinar to learn more about ActiGraft!

The Utilization of an Autologous Topical Blood Tissue Matrix in the Treatment of Chronic Wounds in Patients with Diabetes

Non-CME Webinar: → REGISTERCPME accredited version file for DPMs: → REGISTERCME/CE accredited version file for Nurses and MDs: → REGISTER
crossmenu